KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Enterprise Value (2016 - 2025)

Boston Scientific's Enterprise Value history spans 17 years, with the latest figure at -$1.7 billion for Q4 2025.

  • For Q4 2025, Enterprise Value fell 255.14% year-over-year to -$1.7 billion; the TTM value through Dec 2025 reached -$1.7 billion, down 255.14%, while the annual FY2025 figure was -$1.7 billion, 255.14% down from the prior year.
  • Enterprise Value for Q4 2025 was -$1.7 billion at Boston Scientific, down from -$1.4 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at $120.0 million in Q3 2023 and bottomed at -$2.9 billion in Q2 2021.
  • The 5-year median for Enterprise Value is -$842.0 million (2023), against an average of -$1.2 billion.
  • The largest annual shift saw Enterprise Value soared 117.02% in 2023 before it tumbled 2324.17% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$2.3 billion in 2021, then skyrocketed by 45.44% to -$1.3 billion in 2022, then soared by 43.22% to -$724.0 million in 2023, then surged by 32.87% to -$486.0 million in 2024, then crashed by 255.14% to -$1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Enterprise Value are -$1.7 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$830.0 million (Q2 2025).